Roche Macedonia Donates Funds for Refurbishing the Clinic of Hematology March 2, 2016

Roche-27Roche Macedonia has donated 320,000 MKD to refurbish University Clinic of Hematology in Skopje. The donation from Roche – one of the leading pharmaceutical companies in Macedonia – consisted of high quality medical equipment, servicing old and providing new cytostatic treatments chairs, providing stands for intravenous therapy, and decorating the daily hospital.

Medical Head of University Clinic of Hematology, prof. dr. Lidija Cevreska, said “We are committed to help all of our patients and answer to all their needs in our everyday work. However, the conditions of the daily hospital at our clinic where cancer hematology patients are treated needed improvement mainly due to increasing number of patients and lacking capacity for their treatment in a proper manner.  Roche as a trusted healthcare partner recognized our need and helped us in supporting the cancer hematology patients, by improving the conditions at the Clinic of Hematology. I would like to express our deep gratitude for this humanitarian act on behalf of myself, our technical director Maja Dermendizev and on behalf of all employees from our Clinic.

“We have been actively engaged in supporting the healthcare system in Macedonia in different fields through numerous investments aimed mainly at improving oncology and hematology. This includes donations, professional training, infrastructural projects and clinical trials, which amount to more than five million euros in the last three years alone.

“Our investment of 320.000 MKD for improving the conditions of the daily hospital at the University Clinic of Hematology in Skopje and for patients’ overall sense of well being continues this important investment in Macedonia-” said Balkan Cluster Head for Roche, Ufuk Apaydin.

One of the leading pharmaceutical companies in Macedonia, Roche is also one of the largest innovators in the field of oncological medicines and diagnostics. The company has been operating in the Republic of Macedonia for more than 15 years, while in April 2015 its Skopje office was promoted into a regional centre for the Balkans covering Albania, Kosovo, Montenegro and Moldova.

Mr Apaydin added: “Over the last 15 years we’ve been working to bring patients in Macedonia the global standard in cancer care while also helping to improve the healthcare system.

“We are committed to working in partnership with the health authorities to find joint solutions for healthier and more productive families here in Macedonia.”
About Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarial and cancer medicines. Roche has been recognized as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry seven years in a row by the Dow Jones Sustainability Indices.

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2015 employed more than 91,700 people worldwide. In 2015, Roche invested CHF 9.3 billion in R&D and posted sales of CHF 48.1 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit

Contact details

Business Center City Plaza
Ss. Cyril and Methodius 7, 2nd floor, Skopje
Office phone: 02/ 3103 500
e-mail :

Category: Member News